arrow
C

Cristina Jiménez

hospital universitario de salamanca
H指数:29
被引数:4,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The mutational landscape of resistance to BTK and BCL2 inhibitors in CLL: a real-world multicentric study

BTK和BC L2抑制剂耐药性的突变图谱:一项真实世界多中心研究

2026-09-220
OAAI
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study

定量MYD88 L265P和流式细胞术水平用于IgM异常免疫球蛋白病的预后判断:SAL-TO研究

2026-03-250
OAAI
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry
2024-11-120
OAAI
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient
2023-12-270
OAAI
Clonal architecture and evolutionary history of Waldenstrom's macroglobulinemia at the single-cell level
2023-08-232
OAAI
Report of Consensus Panel 3 from the 11th International workshop on Waldenstrom's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenstrom's Macroglobulinemia

第11届瓦尔登斯特伦巨球蛋白血症国际研讨会共识小组3的报告: 瓦尔登斯特伦巨球蛋白血症的分子诊断建议

2023-03-019
OAAI
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
2023-02-084
OAAI
Diagnostics in Waldenstrom's macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom's Macroglobulinemia
LEUKEMIA
IF13.4
2022-11-2622
OAAI
Molecular remission is an independent predictor of progression-free survival in patients with Waldenstrom macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
2022-10-192
PRE
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
2022-01-2123
OAAI
Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma
2021-10-077
OA
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
2021-04-2614
OAAI
Genetic complexity impacts the clinical outcome of follicular lymphoma patients
2021-01-114
OAAI
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
2020-10-3075
OAAI
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
2020-04-0342
OAAI
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
2020-02-0618
OAAI
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
2020-01-3135
OAAI